Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 33 | 2025 | 185 | 5.430 |
Why?
|
| Bronchopulmonary Dysplasia | 20 | 2025 | 32 | 5.320 |
Why?
|
| Infant, Premature, Diseases | 9 | 2021 | 47 | 2.810 |
Why?
|
| Infant, Newborn | 46 | 2025 | 1363 | 2.520 |
Why?
|
| Oxygen Inhalation Therapy | 7 | 2025 | 58 | 2.420 |
Why?
|
| Apnea | 5 | 2017 | 32 | 1.720 |
Why?
|
| Oximetry | 7 | 2025 | 48 | 1.720 |
Why?
|
| Infant | 28 | 2025 | 1654 | 1.410 |
Why?
|
| Gestational Age | 11 | 2025 | 191 | 1.280 |
Why?
|
| Oxygen | 6 | 2022 | 317 | 1.170 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 61 | 1.010 |
Why?
|
| Child Restraint Systems | 3 | 2017 | 5 | 0.940 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 2 | 2024 | 4 | 0.910 |
Why?
|
| Length of Stay | 3 | 2017 | 810 | 0.890 |
Why?
|
| Carbon Dioxide | 2 | 2024 | 86 | 0.880 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 14 | 0.760 |
Why?
|
| Bradycardia | 4 | 2017 | 33 | 0.740 |
Why?
|
| Ventilator Weaning | 2 | 2011 | 20 | 0.720 |
Why?
|
| Home Care Services, Hospital-Based | 2 | 2020 | 5 | 0.710 |
Why?
|
| Intensive Care Units, Neonatal | 7 | 2025 | 82 | 0.690 |
Why?
|
| Caffeine | 3 | 2017 | 50 | 0.670 |
Why?
|
| Ambulatory Care | 2 | 2024 | 311 | 0.620 |
Why?
|
| Feeding Methods | 1 | 2019 | 10 | 0.620 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 54 | 0.600 |
Why?
|
| Monitoring, Physiologic | 3 | 2024 | 158 | 0.590 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 86 | 0.580 |
Why?
|
| Birth Weight | 2 | 2022 | 85 | 0.570 |
Why?
|
| Humans | 51 | 2025 | 63577 | 0.570 |
Why?
|
| Premature Birth | 4 | 2023 | 112 | 0.570 |
Why?
|
| Neuromuscular Diseases | 2 | 2017 | 22 | 0.560 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 22 | 0.540 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 64 | 0.540 |
Why?
|
| Term Birth | 1 | 2016 | 7 | 0.520 |
Why?
|
| Retrospective Studies | 16 | 2025 | 6643 | 0.520 |
Why?
|
| Down Syndrome | 1 | 2017 | 46 | 0.510 |
Why?
|
| Child, Preschool | 14 | 2025 | 1999 | 0.500 |
Why?
|
| Patient Discharge | 7 | 2022 | 506 | 0.500 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 57 | 0.500 |
Why?
|
| Home Care Services | 3 | 2025 | 98 | 0.490 |
Why?
|
| Hypoxia | 2 | 2014 | 115 | 0.490 |
Why?
|
| Asthma | 2 | 2017 | 466 | 0.470 |
Why?
|
| Respiration | 2 | 2024 | 89 | 0.460 |
Why?
|
| Health Care Costs | 1 | 2017 | 215 | 0.450 |
Why?
|
| Quality of Life | 2 | 2020 | 1241 | 0.440 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 723 | 0.440 |
Why?
|
| Body Weight | 2 | 2020 | 379 | 0.430 |
Why?
|
| Female | 29 | 2025 | 32973 | 0.430 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 5 | 0.420 |
Why?
|
| Respiratory Mechanics | 2 | 2017 | 56 | 0.420 |
Why?
|
| Male | 26 | 2025 | 29957 | 0.420 |
Why?
|
| Deglutition | 1 | 2013 | 19 | 0.420 |
Why?
|
| Child | 14 | 2024 | 4541 | 0.400 |
Why?
|
| Equipment Failure | 1 | 2013 | 68 | 0.390 |
Why?
|
| Eating | 1 | 2013 | 139 | 0.390 |
Why?
|
| Posture | 1 | 2013 | 127 | 0.380 |
Why?
|
| Patient Readmission | 2 | 2017 | 427 | 0.370 |
Why?
|
| Professional Practice | 1 | 2011 | 23 | 0.360 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 136 | 0.340 |
Why?
|
| Hospitalization | 2 | 2023 | 1361 | 0.340 |
Why?
|
| Diuretics | 2 | 2025 | 59 | 0.330 |
Why?
|
| Patient Safety | 1 | 2013 | 243 | 0.330 |
Why?
|
| Infant Equipment | 1 | 2010 | 2 | 0.330 |
Why?
|
| Parents | 3 | 2024 | 393 | 0.310 |
Why?
|
| Analgesics, Opioid | 2 | 2025 | 536 | 0.280 |
Why?
|
| Receptors, IgG | 1 | 2007 | 41 | 0.270 |
Why?
|
| Trachea | 3 | 2017 | 85 | 0.270 |
Why?
|
| Risk Factors | 7 | 2021 | 5316 | 0.270 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2007 | 108 | 0.260 |
Why?
|
| Pneumonia, Bacterial | 1 | 2007 | 89 | 0.260 |
Why?
|
| Logistic Models | 4 | 2015 | 1275 | 0.250 |
Why?
|
| Severity of Illness Index | 4 | 2025 | 1556 | 0.250 |
Why?
|
| Boston | 3 | 2021 | 250 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 775 | 0.230 |
Why?
|
| Furosemide | 1 | 2025 | 20 | 0.230 |
Why?
|
| Vibration | 1 | 2025 | 27 | 0.230 |
Why?
|
| Touch | 1 | 2025 | 27 | 0.230 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2016 | 6 | 0.230 |
Why?
|
| Hypersensitivity | 1 | 2025 | 65 | 0.230 |
Why?
|
| Prospective Studies | 4 | 2025 | 3302 | 0.220 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2025 | 38 | 0.220 |
Why?
|
| Air Pollution, Indoor | 1 | 2024 | 36 | 0.220 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1105 | 0.210 |
Why?
|
| Time Factors | 3 | 2025 | 3731 | 0.210 |
Why?
|
| Pediatrics | 3 | 2017 | 257 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 937 | 0.190 |
Why?
|
| Cannula | 1 | 2022 | 24 | 0.190 |
Why?
|
| United States | 8 | 2022 | 7854 | 0.190 |
Why?
|
| Polysomnography | 2 | 2021 | 58 | 0.190 |
Why?
|
| Reference Values | 2 | 2013 | 331 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 37 | 0.180 |
Why?
|
| Nutrition Policy | 1 | 2021 | 39 | 0.180 |
Why?
|
| Adolescent Development | 1 | 2021 | 16 | 0.180 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 2703 | 0.170 |
Why?
|
| Lung | 2 | 2021 | 955 | 0.170 |
Why?
|
| Tracheomalacia | 2 | 2017 | 5 | 0.170 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 6 | 0.170 |
Why?
|
| Child Development | 1 | 2021 | 84 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 150 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2024 | 706 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2021 | 869 | 0.160 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 28 | 0.150 |
Why?
|
| Infant, Extremely Premature | 1 | 2019 | 38 | 0.150 |
Why?
|
| Respiration Disorders | 1 | 2019 | 25 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 51 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 209 | 0.150 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 297 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2016 | 2575 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2586 | 0.140 |
Why?
|
| Milk, Human | 1 | 2019 | 90 | 0.140 |
Why?
|
| Prevalence | 2 | 2025 | 1387 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2010 | 95 | 0.140 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 509 | 0.140 |
Why?
|
| Mothers | 1 | 2021 | 276 | 0.140 |
Why?
|
| Outpatients | 3 | 2023 | 138 | 0.130 |
Why?
|
| Esophagoplasty | 1 | 2016 | 4 | 0.130 |
Why?
|
| Infant Care | 1 | 2016 | 20 | 0.130 |
Why?
|
| Esophageal Atresia | 1 | 2016 | 9 | 0.130 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2016 | 4 | 0.130 |
Why?
|
| Cost Savings | 1 | 2017 | 53 | 0.130 |
Why?
|
| New England | 2 | 2017 | 274 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2016 | 46 | 0.130 |
Why?
|
| Anastomotic Leak | 1 | 2016 | 35 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 116 | 0.120 |
Why?
|
| Infant, Low Birth Weight | 2 | 2015 | 60 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2016 | 126 | 0.120 |
Why?
|
| Saliva | 1 | 2016 | 103 | 0.120 |
Why?
|
| Tracheobronchomalacia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2019 | 445 | 0.110 |
Why?
|
| Bronchi | 1 | 2015 | 81 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 709 | 0.110 |
Why?
|
| Age Factors | 3 | 2021 | 1565 | 0.110 |
Why?
|
| Sucking Behavior | 1 | 2013 | 1 | 0.110 |
Why?
|
| Barium | 1 | 2013 | 7 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 443 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2025 | 5668 | 0.110 |
Why?
|
| Inpatients | 1 | 2016 | 305 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2016 | 851 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2025 | 1259 | 0.100 |
Why?
|
| Equipment Safety | 1 | 2013 | 24 | 0.100 |
Why?
|
| New York | 1 | 2013 | 145 | 0.100 |
Why?
|
| Respiratory Function Tests | 2 | 2024 | 190 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1290 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 182 | 0.090 |
Why?
|
| Morbidity | 2 | 2022 | 113 | 0.090 |
Why?
|
| Tachykinins | 1 | 2011 | 7 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2013 | 202 | 0.090 |
Why?
|
| Complement C3a | 1 | 2011 | 7 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 358 | 0.090 |
Why?
|
| Vital Signs | 1 | 2011 | 12 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2011 | 26 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2013 | 768 | 0.090 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2011 | 36 | 0.090 |
Why?
|
| Pulmonary Medicine | 1 | 2011 | 41 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 105 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2011 | 94 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2013 | 305 | 0.080 |
Why?
|
| Tracheotomy | 1 | 2010 | 7 | 0.080 |
Why?
|
| Contraindications | 1 | 2010 | 52 | 0.080 |
Why?
|
| Tracheostomy | 2 | 2023 | 36 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1093 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2024 | 426 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1381 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2010 | 183 | 0.070 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 1 | 0.070 |
Why?
|
| Complement C5a | 1 | 2007 | 5 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2007 | 16 | 0.070 |
Why?
|
| Cytokines | 2 | 2011 | 934 | 0.070 |
Why?
|
| Phagocytes | 1 | 2007 | 52 | 0.070 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 54 | 0.070 |
Why?
|
| Leukocytes | 1 | 2007 | 103 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 181 | 0.060 |
Why?
|
| Massachusetts | 2 | 2024 | 2075 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2007 | 265 | 0.060 |
Why?
|
| Babesiosis | 1 | 2006 | 12 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 45 | 0.060 |
Why?
|
| Cell Movement | 1 | 2007 | 456 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2010 | 873 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 16899 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2025 | 28 | 0.060 |
Why?
|
| Survival Rate | 1 | 2007 | 854 | 0.060 |
Why?
|
| Partial Pressure | 1 | 2024 | 9 | 0.050 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 57 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 107 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2021 | 753 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2024 | 68 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 6260 | 0.050 |
Why?
|
| Child Health Services | 1 | 2024 | 63 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2025 | 738 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 864 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 30 | 0.050 |
Why?
|
| Child Day Care Centers | 1 | 2022 | 9 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 55 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 532 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2022 | 99 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 75 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1207 | 0.040 |
Why?
|
| Echocardiography | 1 | 2024 | 502 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2021 | 118 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 1147 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 209 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 201 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3398 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 566 | 0.040 |
Why?
|
| Societies | 1 | 2019 | 24 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1666 | 0.040 |
Why?
|
| Mice | 2 | 2011 | 10849 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 879 | 0.030 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 3 | 0.030 |
Why?
|
| Diverticulum | 1 | 2016 | 12 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 90 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1004 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 137 | 0.030 |
Why?
|
| Animals | 3 | 2011 | 20696 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 290 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 694 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 642 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2045 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 341 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2335 | 0.030 |
Why?
|
| Pneumonia | 1 | 2015 | 291 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2011 | 18 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2464 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 146 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1181 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4717 | 0.020 |
Why?
|
| Respiratory System Abnormalities | 1 | 2010 | 3 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 455 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 542 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 68 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 663 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 259 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 96 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 378 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 103 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 248 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 840 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 770 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 17678 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 113 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2110 | 0.020 |
Why?
|
| Babesia | 1 | 2006 | 1 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 1744 | 0.010 |
Why?
|